help button home button Am J Pathol International Conference on Pathology of Chest Diseases
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Walker, D. H.
Right arrow Articles by Gardner, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walker, D. H.
Right arrow Articles by Gardner, J. J.

American Journal of Pathology, Vol 107, 349-356, Copyright © 1982 by American Society for Investigative Pathology


REGULAR ARTICLES

Pathologic and virologic study of fatal Lassa fever in man

DH Walker, JB McCormick, KM Johnson, PA Webb, G Komba-Kono, LH Elliott and JJ Gardner

Postmortem examination of 21 virologically documented cases of Lassa fever, including 6 complete autopsies, was performed as part of a field study of community-acquired Lassa fever in Sierra Leone. The most consistently observed lesions were hepatocellular, adrenal, and splenic necrosis and adrenal cytoplasmic inclusions. Neither these lesions, nor other milder and less constantly observed lesions such as myocarditis, renal tubular injury, and interstitial pneumonia, appeared severe enough to explain the cause of death in Lassa fever. The central nervous system (CNS) contained no specific lesions. Viral titrations demonstrated high viral content in liver, lung, spleen, kidney, heart, placenta, and mammary gland. Clinical laboratory data included elevation of hepatic enzymes, creatine phosphokinase (CPK), and blood urea nitrogen (BUN). Because of the paucity of pathologic lesions in spite of widely disseminated viral infection, further investigation of humoral inflammatory mechanisms is indicated.


This article has been cited by other articles:


Home page
J. Virol.Home page
L. Martinez-Sobrido, P. Giannakas, B. Cubitt, A. Garcia-Sastre, and J. C. de la Torre
Differential Inhibition of Type I Interferon Induction by Arenavirus Nucleoproteins
J. Virol., November 15, 2007; 81(22): 12696 - 12703.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. Carrion Jr., K. Brasky, K. Mansfield, C. Johnson, M. Gonzales, A. Ticer, I. Lukashevich, S. Tardif, and J. Patterson
Lassa Virus Infection in Experimentally Infected Marmosets: Liver Pathology and Immunophenotypic Alterations in Target Tissues
J. Virol., June 15, 2007; 81(12): 6482 - 6490.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. M. Rojek, C. F. Spiropoulou, K. P. Campbell, and S. Kunz
Old World and Clade C New World Arenaviruses Mimic the Molecular Mechanism of Receptor Recognition Used by {alpha}-Dystroglycan's Host-Derived Ligands
J. Virol., June 1, 2007; 81(11): 5685 - 5695.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
L. Martinez-Sobrido, E. I. Zuniga, D. Rosario, A. Garcia-Sastre, and J. C. de la Torre
Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus.
J. Virol., September 1, 2006; 80(18): 9192 - 9199.
[Abstract] [Full Text] [PDF]


Home page
Am J Trop Med HygHome page
E. SBRANA, R. I. MATEO, S.-Y. XIAO, V. L. POPOV, P. C. NEWMAN, and R. B. TESH
CLINICAL LABORATORY, VIROLOGIC, AND PATHOLOGIC CHANGES IN HAMSTERS EXPERIMENTALLY INFECTED WITH PIRITAL VIRUS (ARENAVIRIDAE): A RODENT MODEL OF LASSA FEVER
Am J Trop Med Hyg, June 1, 2006; 74(6): 1096 - 1102.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Kunz, J. M. Rojek, M. Perez, C. F. Spiropoulou, and M. B. A. Oldstone
Characterization of the Interaction of Lassa Fever Virus with Its Cellular Receptor {alpha}-Dystroglycan
J. Virol., May 15, 2005; 79(10): 5979 - 5987.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Asper, T. Sternsdorf, M. Hass, C. Drosten, A. Rhode, H. Schmitz, and S. Gunther
Inhibition of Different Lassa Virus Strains by Alpha and Gamma Interferons and Comparison with a Less Pathogenic Arenavirus
J. Virol., March 15, 2004; 78(6): 3162 - 3169.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Rambukkana, S. Kunz, J. Min, K. P. Campbell, and M. B. A. Oldstone
Targeting Schwann cells by nonlytic arenaviral infection selectively inhibits myelination
PNAS, December 23, 2003; 100(26): 16071 - 16076.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
I. S. Lukashevich, I. Tikhonov, J. D. Rodas, J. C. Zapata, Y. Yang, M. Djavani, and M. S. Salvato
Arenavirus-Mediated Liver Pathology: Acute Lymphocytic Choriomeningitis Virus Infection of Rhesus Macaques Is Characterized by High-Level Interleukin-6 Expression and Hepatocyte Proliferation
J. Virol., February 1, 2003; 77(3): 1727 - 1737.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
O. Lenz, J. ter Meulen, H.-D. Klenk, N. G. Seidah, and W. Garten
The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P
PNAS, October 12, 2001; (2001) 221447598.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
O. Lenz, J. ter Meulen, H.-D. Klenk, N. G. Seidah, and W. Garten
The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P
PNAS, October 23, 2001; 98(22): 12701 - 12705.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1982 by the American Society for Investigative Pathology.